Context Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 10.68 M | $15.70 M | -27.38% | 11.22% |
| BLUE OWL CAPITAL HOLDINGS LP | 02/20/2026 | 7.43 M | $10.93 M | 0.34% | 7.81% |
| NEXTECH INVEST, LTD. | 02/17/2026 | 7.42 M | $10.91 M | 0.00% | 7.79% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 7.42 M | $10.91 M | 0.00% | 7.79% |
| AVIDITY PARTNERS MANAGEMENT LP | 02/13/2026 | 5.50 M | $8.09 M | -38.71% | 5.78% |
| GREAT POINT PARTNERS LLC | 02/17/2026 | 4.68 M | $6.89 M | 0.00% | 4.92% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 4.00 M | $5.88 M | 0.00% | 4.21% |
| VANGUARD GROUP INC | 01/29/2026 | 3.79 M | $5.57 M | 8.32% | 3.98% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 2.60 M | $3.82 M | 100.00% | 2.73% |
| MARSHALL WACE, LLP | 02/13/2026 | 2.59 M | $3.81 M | 7,153.70% | 2.72% |
| BLACKSTONE INC. | 02/17/2026 | 2.44 M | $3.59 M | 0.00% | 2.56% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/13/2026 | 1.66 M | $2.45 M | 0.00% | 1.75% |
| SIO CAPITAL MANAGEMENT, LLC | 02/17/2026 | 1.34 M | $1.97 M | 0.00% | 1.41% |
| BLACKROCK, INC. | 02/12/2026 | 848.05 K | $1.25 M | -0.11% | 0.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 608.46 K | $894.88 K | -0.02% | 0.64% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 508.33 K | $747.24 K | 58.79% | 0.53% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 351.09 K | $516.11 K | 0.00% | 0.37% |
| STATE STREET CORP | 02/13/2026 | 165.61 K | $243.44 K | 8.52% | 0.17% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 132.79 K | $195.20 K | 0.00% | 0.14% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 125.85 K | $185.00 K | 0.00% | 0.13% |
| PATHSTONE HOLDINGS, LLC | 02/13/2026 | 110.24 K | $162.06 K | 0.00% | 0.12% |
| MILL CREEK CAPITAL ADVISORS, LLC | 02/13/2026 | 104.63 K | $153.81 K | 0.00% | 0.11% |
| XTX TOPCO LTD | 02/17/2026 | 101.61 K | $149.36 K | 858.81% | 0.11% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/13/2026 | 100.00 K | $147.00 K | 0.00% | 0.11% |
| CLEAR HARBOR ASSET MANAGEMENT, LLC | 02/10/2026 | 92.80 K | $136.42 K | 0.00% | 0.10% |
| NORTHERN TRUST CORP | 02/17/2026 | 84.28 K | $123.89 K | 26.96% | 0.09% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 52.70 K | $77.47 K | 100.00% | 0.06% |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 46.22 K | $67.94 K | 100.00% | 0.05% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 37.84 K | $55.62 K | -97.72% | 0.04% |
| CITADEL ADVISORS LLC | 02/17/2026 | 34.38 K | $50.54 K | -66.74% | 0.04% |
| VIRTU FINANCIAL LLC | 02/23/2026 | 28.92 K | $43.00 K | 100.00% | 0.03% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 25.50 K | $37.49 K | 0.00% | 0.03% |
| CERITY PARTNERS LLC | 02/11/2026 | 20.00 K | $29.40 K | 0.00% | 0.02% |
| CAXTON CORP | 02/13/2026 | 18.40 K | $27.05 K | 0.00% | 0.02% |
| CI PRIVATE WEALTH, LLC | 03/09/2026 | 15.08 K | $22.17 K | 100.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 9.61 K | $14.13 K | 100.00% | 0.01% |
| 02/18/2026 | 1.70 K | $2.50 K | 100.00% | 0.00% | |
| FARTHER FINANCE ADVISORS, LLC | 01/23/2026 | 1.50 K | $2.21 K | 100.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 1.35 K | $1.98 K | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 933 | $1.37 K | 114.98% | 0.00% |
| UBS GROUP AG | 01/29/2026 | 490 | $720 | -93.36% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 114 | $168 | -2.56% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Context Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 59 institutional investors and hedge funds held shares of Context Therapeutics Inc. The most heavily invested institutionals were:
JANE STREET GROUP, LLC: 436,931
VANGUARD FIDUCIARY TRUST CO: 341,344
HighTower Advisors, LLC: 126,152
Pathstone Holdings, LLC: 110,244
Clear Harbor Asset Management, LLC: 92,804
WINTON GROUP Ltd: 81,303
68.50% of Context Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 74.61 M shares in the last 24 months. This purchase volume represents approximately $216.37 M in transactions.